FCELB
FUELCELL ENERGY INC
$425.05
-4.27%
$926.6M
No data for this timeframe.
Vol
Market Cap$926.6M
Cap SizeSmall Cap
SEC Reports3
Recent Activity
Jun 8, 2026
SEC
FuelCell Energy filed an automatic shelf registration statement (S-3ASR) registering an indeterminate amount of common s
S-3ASR — Impact 6/10
Jun 8, 2026
SEC
FuelCell Energy reported Q2 FY2026 revenue of $35.6M, a 5% YoY decline and below the $40.5M consensus estimate. GAAP net
8-K — Impact 6/10
May 21, 2026
SEC
FuelCell Energy elected John Livingston, a cybersecurity entrepreneur and former McKinsey partner, to its Board of Direc
8-K — Impact 2/10
Analyst Ratings
0Strong Buy
0Buy
8Hold
3Sell
2Strong Sell
Latest Reports
BEARISH
S-3ASR
6/10
FuelCell Energy filed an automatic shelf registration statement (S-3ASR) registering an indeterminate amount of common s
Jun 8, 2026
BEARISH
8-K
6/10
FuelCell Energy reported Q2 FY2026 revenue of $35.6M, a 5% YoY decline and below the $40.5M consensus estimate. GAAP net
Jun 8, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 1 neutral. Avg impact: 4.7/10.
BEARISH
S-3ASR
6/10
FuelCell Energy filed an automatic shelf registration statement (S-3ASR) registering an indeterminat
Jun 8, 2026
BEARISH
8-K
6/10
FuelCell Energy reported Q2 FY2026 revenue of $35.6M, a 5% YoY decline and below the $40.5M consensu
Jun 8, 2026
NEUTRAL
8-K
2/10
FuelCell Energy elected John Livingston, a cybersecurity entrepreneur and former McKinsey partner, t
May 21, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 0% buy across 13 analysts — 0 strong buy, 0 buy, 8 hold, 3 sell, 2 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-07-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -17.8% | — |
| Next Q 2026-10-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -17.8% | — |
| Current FY 2026-10-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.2B | -4.4% | — |
| Next FY 2027-10-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.2B | 51.1% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 8 | 3 | 2 | 0% | |
| May 1, 2026 | 0 | 0 | 8 | 3 | 2 | 0% | |
| Apr 1, 2026 | 0 | 0 | 8 | 3 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 8 | 3 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 8 | 3 | 2 | 0% | |
| Jan 1, 2026 | 0 | 0 | 8 | 3 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.